22 results  1 of 2 

1 Analgesic effects of ultrasound-guided fourquadrant transversus abdominis plane in patients with cytoreductive surgery with hyperthermic intraperitoneal chemotherapy: a prospective, randomized, controlled study
Jaegyok Song, Nayoung Choi, Minji Kang, Sung Mi Ji, Dong-wook Kim, Min A Kwon
Anesth Pain Med.2022;17(1):75-86.   Published online 2022 January 19     DOI: http://dx.doi.org/10.17085/apm.21094
      
2 Robotic assisted cytoreductive surgery, removal of a recurrent disease in the right pericaval lymph node in a patient with ovarian cancer with the robotic Xi platform
Massoud Shoraka, Hadeer Metwally, Semiramis Carbajal-Mamani, Joel Cardenas-Goicoechea
Obstet Gynecol Sci.2021;64(6):560-564.   Published online 2021 August 13     DOI: http://dx.doi.org/10.5468/ogs.21202
      
3 Treatment options for advanced gastric cancer with peritoneal metastasis: experience from a single institution in Korea
Dong-Wook Kim, Sang Il Youn, Ye Seob Jee
Ann Surg Treat Res.2021;100(4):209-217.   Published online 2021 March 30     DOI: http://dx.doi.org/10.4174/astr.2021.100.4.209
      
4 Evaluation of the relationship between lactacidemia and postoperative complications after surgery for peritoneal carcinomatosis
Marta Soriano Hervás, Rosa Játiva-Porcar, Daniel Robles-Hernández, Anna Serra Rubert, Blanca Segarra, Cristina Oliva, Javier Escrig, José Antonio Llueca
Korean J Anesthesiol.2021;74(1):45-52.   Published online 2020 May 20     DOI: http://dx.doi.org/10.4097/kja.20089
      
5 Factors associated with surgical morbidity of primary debulking in epithelial ovarian cancer
Emre Günakan, Yusuf Aytaç Tohma, Mehmet Tunç, Hüseyin Akıllı, Hanifi Şahin, Ali Ayhan
Obstet Gynecol Sci.2020;63(1):64-71.   Published online 2019 December 31     DOI: http://dx.doi.org/10.5468/ogs.2020.63.1.64
      
6 Well-trained gynecologic oncologists can perform bowel resection and upper abdominal surgery safely
Kyoko Nishikimi, Shinichi Tate, Kazuyoshi Kato, Ayumu Matsuoka, Makio Shozu
J Gynecol Oncol.2020;31(1):e3.  Published online 2019 October 4     DOI: http://dx.doi.org/10.3802/jgo.2020.31.e3
      
7 Characteristics and survival of ovarian cancer patients treated with neoadjuvant chemotherapy but not undergoing interval debulking surgery
Ying L. Liu, Olga T. Filippova, Qin Zhou, Alexia Iasonos, Dennis S. Chi, Oliver Zivanovic, Yukio Sonoda, Ginger J. Gardner, Vance A. Broach, Roisin E. O'Cearbhaill, Jason A. Konner, Carol Aghajanian, Kara Long Roche, William P. Tew
J Gynecol Oncol.2020;31(1):e17.  Published online 2019 September 9     DOI: http://dx.doi.org/10.3802/jgo.2020.31.e17
      
8 The efficacy of secondary cytoreductive surgery for recurrent ovarian, tubal, or peritoneal cancer in Tian-model low-risk patients
Makiko So, Taito Miyamoto, Ryusuke Murakami, Kaoru Abiko, Junzo Hamanishi, Tsukasa Baba, Masaki Mandai
J Gynecol Oncol.2019;30(6):e100.  Published online 2019 June 10     DOI: http://dx.doi.org/10.3802/jgo.2019.30.e100
      
9 Treatment strategies for patients with advanced ovarian cancer undergoing neoadjuvant chemotherapy: interval debulking surgery or additional chemotherapy?
Yutaka Yoneoka, Mitsuya Ishikawa, Takashi Uehara, Hanako Shimizu, Masaya Uno, Takashi Murakami, Tomoyasu Kato
J Gynecol Oncol.2019;30(5):e81.  Published online 2019 March 29     DOI: http://dx.doi.org/10.3802/jgo.2019.30.e81
      
10 Pharmacokinetics of cisplatin during open and minimally-invasive secondary cytoreductive surgery plus HIPEC in women with platinum-sensitive recurrent ovarian cancer: a prospective study
Marco Petrillo, Massimo Zucchetti, Stefano Cianci, Lavinia Morosi, Carlo Ronsini, Andrea Colombo, Maurizio D'Incalci, Giovanni Scambia, Anna Fagotti
J Gynecol Oncol.2019;30(4):e59.  Published online 2019 March 1     DOI: http://dx.doi.org/10.3802/jgo.2019.30.e59
      
11 Bowel resection rate but not bowel related morbidity is decreased after interval debulking surgery compared to primary surgery in patents with stage IIIC–IV ovarian cancer
Roberto Tozzi, Jvan Casarin, Ahmet Baysal, Gaetano Valenti, Yakup Kilic, Hooman Soleymani Majd, Matteo Morotti
J Gynecol Oncol.2019;30(2):e25.  Published online 2018 November 30     DOI: http://dx.doi.org/10.3802/jgo.2019.30.e25
      
12 The detrimental effect of adopting interval debulking surgery in advanced stage low-grade serous ovarian cancer
Giorgio Bogani, Umberto Leone Roberti Maggiore, Biagio Paolini, Antonino Diito, Fabio Martinelli, Domenica Lorusso, Francesco Raspagliesi
J Gynecol Oncol.2019;30(1):e4.  Published online 2018 September 12     DOI: http://dx.doi.org/10.3802/jgo.2019.30.e4
      
13 A score system for complete cytoreduction in selected recurrent ovarian cancer patients undergoing secondary cytoreductive surgery: predictors- and nomogram-based analyses
Giorgio Bogani, Elena Tagliabue, Mauro Signorelli, Antonino Ditto, Fabio Martinelli, Valentina Chiappa, Lavinia Mosca, Ilaria Sabatucci, Umberto Leone, Roberti Maggiore, Domenica Lorusso, Francesco Raspagliesi
J Gynecol Oncol.2018;29(3):e40.  Published online 2018 May 4     DOI: http://dx.doi.org/10.3802/jgo.2018.29.e40
      
14 Effect of cytoreductive surgery and hyperthermic intraperitoneal chemotherapy on relapse pattern in primary epithelial ovarian cancer: a propensity score based case-control study
Marco Ceresoli, Apollonia Verrengia, Giulia Montori, Luisa Busci, Federico Coccolini, Luca Ansaloni, Luigi Frigerio
J Gynecol Oncol.2018;29(3):e53.  Published online 2018 March 12     DOI: http://dx.doi.org/10.3802/jgo.2018.29.e53
      
15 Peritoneal cancer index as a predictor of survival in advanced stage serous epithelial ovarian cancer: a prospective study
Alaa A. Elzarkaa, Waleed Shaalan, Doaa Elemam, Hassan Mansour, Mahmoud Melis, Eduard Malik, Amr A. Soliman
J Gynecol Oncol.2018;29(4):e47.  Published online 2018 March 8     DOI: http://dx.doi.org/10.3802/jgo.2018.29.e47
      
16 A score system for complete cytoreduction in selected recurrent ovarian cancer patients undergoing secondary cytoreductive surgery: predictors- and nomogram-based analyses
Giorgio Bogani, Elena Tagliabue, Mauro Signorelli, Antonino Ditto, Fabio Martinelli, Valentina Chiappa, Lavinia Mosca, Ilaria Sabatucci, Umberto Leone Roberti Maggiore, Domenica Lorusso, Francesco Raspagliesi
J Gynecol Oncol.2018;29(3):e40.  Published online 2018 February 23     DOI: http://dx.doi.org/10.3802/jgo.2018.29.e40
      
17 Diagnostic value of integrated 18F-fluoro-2-deoxyglucose positron emission tomography/computed tomography in recurrent epithelial ovarian cancer: accuracy of patient selection for secondary cytoreduction in 134 patients
Young-Jae Lee, Yong-Man Kim, Phill-Seung Jung, Jong-Jin Lee, Jeong-Kon Kim, Young-Tak Kim, Joo-Hyun Nam
J Gynecol Oncol.2018;29(3):e36.  Published online 2018 February 1     DOI: http://dx.doi.org/10.3802/jgo.2018.29.e36
      
18 Surgical management of ovarian cancer
Suk-Joon Chang
J Korean Med Assoc.2016;59(3):167-174.   Published online 2016 March 18     DOI: http://dx.doi.org/10.5124/jkma.2016.59.3.167
      
19 Feasibility of laparoscopic cytoreduction in patients with localized recurrent epithelial ovarian cancer
E Sun Paik, Yoo-Young Lee, Tae-Joong Kim, Chel Hun Choi, Jeong-Won Lee, Byoung-Gie Kim, Duk-Soo Bae
J Gynecol Oncol.2016;27(3):e24.  Published online 2016 January 4     DOI: http://dx.doi.org/10.3802/jgo.2016.27.e24
      
20 Clinical significance of systematic retroperitoneal lymphadenectomy during interval debulking surgery in advanced ovarian cancer patients
Haruko Iwase, Toshio Takada, Chiaki Iitsuka, Hidetaka Nomura, Akiko Abe, Tomoko Taniguchi, Ken Takizawa
J Gynecol Oncol.2015;26(4):303-310.   Published online 2015 July 17     DOI: http://dx.doi.org/10.3802/jgo.2015.26.4.303
      

 1 of 2